PATENT CLAIM ANALYSIS

Application Number: 15763156
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["544", "322000"]

Abstract:
The present invention provides an EGFR kinase inhibitor and a preparation method and use thereof. Specifically, the present invention provides a compound as shown in formula (I), the definition of each group therein being as described in the description. Said compound is an efficient EGFR inhibitor.

Claim (Index 4):
The compound of  claim 1 , wherein the compound of formula (I) is selected from the following group:

Metadata:
- Claim Count in Document: 15.0
- Percentile: 96.0
- Lexical Diversity: 1.43243
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12396084', '15504854', '13035640', '15269069', '14403014']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8327900969037081
- 35 USC 102 Novelty (BERT): 0.5395405386812283
- Combined Prediction Score: 0.80346514108146
- Mean Citation Score: 393.711004
- Max Citation Score: 396.90054
- Similarity Product: 321.79998530405044

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test